Fig. 4.
Fig. 4. Triple-color analysis of primitive markers on CD34+CD164(103B2/9E10 epitope)+ bone marrow cells. CD34+ bone marrow cells were labeled with 103B2/9E10 plus CD34-PerCP and with each of the antibody PE conjugates indicated before staining with FITC-F(ab)2 goat anti-mouse IgG3. Plots are two-color dot plot displays from a representative experiment of CD34 purified cells gated on forward and side scatter parameters (left top dot plot) and on PerCP-CD34+ fluorescence and side scatter (middle dot plot). The arbitrary gates indicated on the dot plots were determined with appropriate isotype-matched negative controls. Examples of the IgG1/IgG3 isotype negative controls (top right dot plot) and of CD164(103B2/9E10 epitope)/anti–IgG3-FITC staining plus labeling with a nonbinding PE-conjugated anti–glycophorin A conjugate (bottom right dot plot) are indicated. Similar results were obtained for the IgG1/IgG2a isotype negative controls.

Triple-color analysis of primitive markers on CD34+CD164(103B2/9E10 epitope)+ bone marrow cells. CD34+ bone marrow cells were labeled with 103B2/9E10 plus CD34-PerCP and with each of the antibody PE conjugates indicated before staining with FITC-F(ab)2 goat anti-mouse IgG3. Plots are two-color dot plot displays from a representative experiment of CD34 purified cells gated on forward and side scatter parameters (left top dot plot) and on PerCP-CD34+ fluorescence and side scatter (middle dot plot). The arbitrary gates indicated on the dot plots were determined with appropriate isotype-matched negative controls. Examples of the IgG1/IgG3 isotype negative controls (top right dot plot) and of CD164(103B2/9E10 epitope)/anti–IgG3-FITC staining plus labeling with a nonbinding PE-conjugated anti–glycophorin A conjugate (bottom right dot plot) are indicated. Similar results were obtained for the IgG1/IgG2a isotype negative controls.

Close Modal

or Create an Account

Close Modal
Close Modal